Clinical validation and accuracy assessment of the Capsule Endoscopy‐Crohn's Disease index (CE‐CD)
Journal of Pediatric Gastroenterology and Nutrition · 2024
DOI: 10.1002/jpn3.12253 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von José Vicente Arcos-Machancoses und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology, Hepatology and Nutrition, Hospital Clínic Universitari de València, València, Spain. Hauptthemen laut MEDLINE: Crohn Disease, Capsule Endoscopy, Severity of Illness Index. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Objectives
To compare the recently proposed Capsule Endoscopy‐Crohn's Disease index (CE‐CD) to pre‐existing capsule endoscopy (CE) scores, to measure its precision and accuracy to predict adverse clinical outcomes in children with Crohn's disease (CD).
Methods
Children with CD who underwent CE at diagnosis and had, at least, 1‐year follow‐up postprocedure were selected. Capsule study was viewed and the different indices were independently scored by two trained paediatric gastroenterologists. The relationship between pre‐existing scores and CE‐CD was assessed by linear regression analysis. Clinical outcomes prediction assessment was based on receiver operating characteristics curves, survival analysis and Cox regression. Finally, interobserver agreement was measured.
Results
Fifty‐nine patients were finally included. CE‐CD showed a strong positive correlation with the Lewis score ( ρ = 0.947) and the Capsule Endoscopy Crohn's Disease Activity Index (CECDAI) ( ρ = 0.982). Both CE‐CD and CECDAI were significant predictors of treatment escalation (hazard ratio 1.07 and 1.09, respectively, with both p ‐values < 0.01). However, no score predicted risk of hospital admission, surgery or clinical/endoscopic relapse. The presence of moderate‐to‐severe small bowel (SB) inflammation, defined as a score of ≥9 on CE‐CD, provided a hazard ratio of treatment escalation of 2.6 (95% confidence interval: 1.3–5.3). This cut‐off provided the optimal sensitivity/specificity pair: 48.4%/89.3%. No interobserver misclassification among inflammation categories given by CE‐CD were observed (kappa 100%).
Conclusion
CE‐CD is a useful tool to document SB inflammation in children with CD. It correlates strongly with classical scores, can better predict need for treatment escalation and shows good interobserver agreement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatric Gastroenterology, Hepatology and Nutrition, Hospital Clínic Universitari de València, València, Spain.
- Department of Paediatric Gastroenterology, Hepatology and Nutrition, Sheffield Children's Hospital, Sheffield, UK.
ORCID-Profile: José Vicente Arcos-Machancoses
Förderung
- None
Zitieren
APA
Arcos-Machancoses, J. V., Kapoor, A., Schluckebier, D., & Thomson, M. (2024). Clinical validation and accuracy assessment of the Capsule Endoscopy‐Crohn's Disease index (CE‐CD). Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12253
Vancouver
Arcos-Machancoses JV, Kapoor A, Schluckebier D, Thomson M. Clinical validation and accuracy assessment of the Capsule Endoscopy‐Crohn's Disease index (CE‐CD). Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12253
BibTeX
@article{ArcosMachancoses2024,
author = {Arcos-Machancoses, José Vicente and Kapoor, Akshay and Schluckebier, Dominique and Thomson, Mike},
title = {Clinical validation and accuracy assessment of the Capsule Endoscopy‐Crohn's Disease index (CE‐CD)},
journal = {Journal of Pediatric Gastroenterology and Nutrition},
year = {2024},
doi = {10.1002/jpn3.12253}
}
EUVIMED